PCR-generated linear DNA fragments utilized as a hantavirus DNA vaccine.
The field of DNA vaccines has grown rapidly, and since most such vaccines involve the inoculation of large circular DNA molecules previously propagated in bacteria, several inconveniences (e.g. the presence of antibiotic resistance genes, impurities from bacterial cultures or inefficient uptake of the large and bulky plasmid DNA molecules to the nucleus) are debated. In this study, we have explored the possibility of using smaller and more flexible PCR-generated linear DNA fragments instead. Phosphorothioate (PTO)-modified primers were used successfully to protect the PCR-generated DNA fragments from exonuclease degradation, and by using a nuclear localization signal-peptide to target the linear DNA to the nucleus the immune response against the encoded antigen was further improved. This approach was tested in cell culture using a sensitive reporter system and in vivo with DNA encoding the amino-terminus of the Puumala hantavirus nucleocapsid protein. Our results indicate that linear DNA fragments have a great potential as a genetic vaccine and phosphorothioate modification in combination with a nuclear localization signal peptide increase the stability and targets the linear DNA molecules to the nucleus resulting in an improved biological response examined both in vitro and in vivo.
Johansson
P
P
Department of Medical Countermeasures, Division of NBC Defence, Swedish Defence Research Agency, SE-90182 Umeå, Sweden.
Lindgren
T
T
Lundström
M
M
Holmström
A
A
Elgh
F
F
Bucht
G
G
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D001483:Base Sequence; D019470:Biolistics; D002460:Cell Line; D004279:DNA, Viral / Q000235:genetics; D005260:Female; D006476:Orthohantavirus / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007700:Kinetics; D051379:Mice; D008807:Mice, Inbred BALB C; D016133:Polymerase Chain Reaction; D019444:Vaccines, DNA / Q000235:genetics; D014765:Viral Vaccines / Q000235:genetics*
D000914:Antibodies, Viral; D004279:DNA, Viral; D019444:Vaccines, DNA; D014765:Viral Vaccines